The Inflation Reduction Act, a massive climate, tax, and healthcare bill, has implications for the self-funded community. It's true that certain highly anticipated portions of the bill were removed, including insulin price caps for all group health plans, but this bill is still relevant for employers with self-funded plans.
Prescription Drug Price Negotiation
Subtitle B of the Inflation Reduction Act addresses one of the pitfalls in the creation of Medicare Part D program, which prohibited Medicare from negotiating the price of prescription drugs. This will allow Medicare to negotiate for the price of prescription drugs starting in 2026. This program will begin with a list of the top 10 most expensive drugs covered under Part D and will gradually expand to 20 prescription drugs in 2029.
Complete your profile to continue reading and get FREE access to Treasury & Risk, part of your ALM digital membership.
Your access to unlimited Treasury & Risk content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical Treasury & Risk information including in-depth analysis of treasury and finance best practices, case studies with corporate innovators, informative newsletters, educational webcasts and videos, and resources from industry leaders.
- Exclusive discounts on ALM and Treasury & Risk events.
- Access to other award-winning ALM websites including PropertyCasualty360.com and Law.com.
*May exclude premium content
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
